Published in Blood Coagul Fibrinolysis on June 01, 2011
Simulated Thrombin Generation in the Presence of Surface-Bound Heparin and Circulating Tissue Factor. Ann Biomed Eng (2015) 0.77
Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells. Int J Mol Sci (2017) 0.75
Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis. Int J Mol Sci (2017) 0.75
Analysis of the potential of cancer cell lines to release tissue factor-containing microvesicles: correlation with tissue factor and PAR2 expression. Thromb J (2016) 0.75
Targeting Platelets for the Treatment of Cancer. Cancers (Basel) (2017) 0.75
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol (2008) 5.77
Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med (2005) 4.80
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost (2007) 3.67
Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med (2008) 3.56
Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet (2008) 3.33
Safety of ventilation/perfusion single photon emission computed tomography for pulmonary embolism diagnosis. Eur J Nucl Med Mol Imaging (2014) 1.98
Accuracy of multislice computed tomography in the preoperative assessment of coronary disease in patients with aortic valve stenosis. J Am Coll Cardiol (2006) 1.85
Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med (2008) 1.71
Midterm prognosis of patients with suspected coronary artery disease and normal multislice computed tomographic findings: a prospective management outcome study. Arch Intern Med (2007) 1.71
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ (2008) 1.71
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med (2010) 1.68
Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein. Thromb Haemost (2003) 1.66
Investigations for bone metastasis from an unknown primary. Joint Bone Spine (2006) 1.57
Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism. Thromb Haemost (2009) 1.51
Lipid lowering drugs and the risk of recurrent venous thromboembolism. Thromb Res (2012) 1.51
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study. Thromb Haemost (2013) 1.47
Medium-term survival of diffuse coronary artery disease patients following coronary artery reconstruction with the internal thoracic artery. Cardiology (2012) 1.43
Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost (2008) 1.36
Clinical relevance of distal deep vein thrombosis. Review of literature data. Thromb Haemost (2006) 1.25
VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies. Thromb Haemost (2009) 1.07
Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb Haemost (2006) 1.05
Use of anticoagulants in elderly patients: practical recommendations. Clin Interv Aging (2009) 1.04
Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest (2009) 1.03
Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic study. Thromb Haemost (2007) 1.03
Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis. Thromb Res (2013) 1.03
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica (2012) 1.00
The challenge of diagnosing pulmonary embolism in elderly patients: influence of age on commonly used diagnostic tests and strategies. J Am Geriatr Soc (2005) 0.99
Benfluorex and unexplained valvular heart disease: a case-control study. PLoS One (2010) 0.97
Cardiac tamponade in medical patients: a 10-year follow-up survey. Cardiology (2008) 0.96
Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study. Fundam Clin Pharmacol (2004) 0.95
Diagnostic value of D-dimer in patients with suspected pulmonary embolism: results from a multicentre outcome study. Thromb Res (2006) 0.92
Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial. Arterioscler Thromb Vasc Biol (2003) 0.91
Rituximab's cost for the treatment of primary cold agglutinin disease should not limit its use. Haematologica (2006) 0.91
Management of severe ischemia of the hand following intra-arterial injection. Thromb Haemost (2005) 0.91
High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients. Thromb Haemost (2002) 0.91
High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly. Haematologica (2003) 0.90
Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality. Fundam Clin Pharmacol (2007) 0.90
Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. Thromb Haemost (2006) 0.90
Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study. Clin Endocrinol (Oxf) (2007) 0.88
The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles. Thromb Haemost (2012) 0.88
External validation of a D-dimer age-adjusted cut-off for the exclusion of pulmonary embolism. Thromb Haemost (2012) 0.86
Transthoracic sonography of the lung and pleura in view of a suspected pulmonary embolism: a pilot study. J Ultrasound Med (2003) 0.86
Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia. Br J Haematol (2009) 0.85
Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction. Blood Coagul Fibrinolysis (2009) 0.85
Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma. Blood Coagul Fibrinolysis (2004) 0.84
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thromb Haemost (2010) 0.83
Intermittent pneumatic compression to prevent venous thromboembolism in patients with high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial. Intensive Care Med (2013) 0.83
V/Q SPECT interpretation for pulmonary embolism diagnosis: which criteria to use? J Nucl Med (2013) 0.83
Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study. Thromb Haemost (2008) 0.82
Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol (2009) 0.82
Family history as a risk factor for venous thromboembolism. Thromb Res (2008) 0.82
Pulmonary cement embolism after vertebroplasty. Thromb Haemost (2006) 0.82
Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood (2013) 0.81
Incidence of venous thromboembolism in psychiatric units. Thromb Res (2012) 0.81
Phenotypic but not allelic ABO blood group association with risk of venous thrombosis. Thromb Haemost (2005) 0.81
Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study. Thromb Haemost (2010) 0.81
Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids. Blood Coagul Fibrinolysis (2009) 0.81
High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis. Thromb Haemost (2007) 0.81
Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia? Thromb Res (2007) 0.80
The first assessment of soluble CD146 in women with unexplained pregnancy loss. A new insight? Thromb Haemost (2005) 0.80
Diagnostic accuracy of single-photon emission tomography ventilation/perfusion lung scan in the diagnosis of pulmonary embolism. Chest (2011) 0.80
The use of epicardial electrogram as a simple guide to select the optimal site of left ventricular pacing in cardiac resynchronization therapy. Cardiol Res Pract (2011) 0.80
Single complete compression ultrasonography for suspected deep venous thrombosis: ideal in routine clinical practice? Ann Intern Med (2004) 0.80
[Incidence and risk factors for venous thromboembolism]. Rev Prat (2007) 0.80
Estrogen receptor alpha polymorphism and venous thromboembolism in male and female: data from the EDITH study. Thromb Res (2006) 0.79
Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism. Thromb Res (2007) 0.79
Increased thrombin generation measured in the presence of thrombomodulin in women with early pregnancy loss. Fertil Steril (2010) 0.79
Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability. BMC Cancer (2014) 0.79